DXCM vs. FMS: DexCom vs. Fresenius Medical Care Stock Comparison

November 11, 2026

How do DexCom (DXCM) and Fresenius Medical Care (FMS) stack up? This page sets them side by side across company profile, performance and risk, profitability, growth, financial strength, dividends, and valuation, with selected fundamentals also measured against each stock's industry-group peers.

Company Profile

DexCom (DXCM) and Fresenius Medical Care (FMS) both fall under the Health Care Equipment & Services industry group, but DXCM is classified in Health Care Equipment & Supplies while FMS is classified in Health Care Providers & Services.

DexCom (DXCM) trades as ordinary local shares, while Fresenius Medical Care (FMS) trades as an ADR — compare with FX exposure, depositary-program fees, and dividend-withholding-tax differences in mind.

Company profile comparison for DexCom (DXCM) and Fresenius Medical Care (FMS)
Profile Item	DXCM	FMS
Name	DexCom Inc.	Fresenius Medical Care AG - Depositary Receipt
Country/Region	United States	Germany
GICS Sector	Health Care	Health Care
GICS Industry Group	Health Care Equipment & Services	Health Care Equipment & Services
GICS Industry	Health Care Equipment & Supplies	Health Care Providers & Services
GICS Sub-Industry	Health Care Equipment	Health Care Services
Market Capitalization	29.62 billion USD	12.15 billion USD
Currency	USD	USD
Exchange	Nasdaq	NYSE
Listing Date	April 14, 2005	September 17, 1996
Security Type	Common Stock	ADR

Price Performance

Cumulative Growth

DXCM

FMS

GSPC

DexCom (DXCM) vs. Fresenius Medical Care (FMS), with S&P 500 (GSPC) for reference: Growth of a $10,000 investment over the past five years. Adjusted for dividends and splits.

Trailing Returns

Loading price history…

Trailing total returns for DexCom (DXCM) and Fresenius Medical Care (FMS). Returns over one year are annualized.

Calendar-Year Returns

Loading price history…

Calendar-year total returns for DexCom (DXCM) and Fresenius Medical Care (FMS). Each bar is that year's total return, measured year-end to year-end.

Performance Metrics

Price performance metrics for DexCom (DXCM) and Fresenius Medical Care (FMS)
Metric	DXCM	FMS
Total Return (1Y)	46.33%	-0.71%
Total Return (3Y, Annualized)	-4.50%	13.88%
Total Return (5Y, Annualized)	-12.76%	-4.69%

Risk Profile

Drawdown History

DXCM

FMS

GSPC

DexCom (DXCM) vs. Fresenius Medical Care (FMS), with S&P 500 (GSPC) for reference: Drawdown from the running peak over the past five years. Each line shows the decline from its prior peak; 0% marks a new high.

Return Distribution

Loading price history…

Distribution of monthly total returns for DexCom (DXCM) and Fresenius Medical Care (FMS). Each bar is the share of months whose return fell in that 5% bucket.

Risk Metrics

Risk profile metrics for DexCom (DXCM) and Fresenius Medical Care (FMS)
Metric	DXCM	FMS
Volatility (1Y, Annualized)	38.37%	30.61%
Beta (5Y)	1.43	0.77
Max Drawdown (5Y)	-66.32%	-62.33%
Avg. Volume (3M)	4.34M	954.21K

Risk-Adjusted Performance

Risk-Return Positioning

DXCM and FMS are plotted by 1-year volatility (risk) and 1-year return. The dashed Capital Allocation Line runs from the risk-free rate through the shared industry median.

Risk-Adjusted Metrics

Risk-adjusted metrics for DexCom (DXCM) and Fresenius Medical Care (FMS)
Metric	DXCM	FMS
Sharpe Ratio (1Y)	1.10	-0.16
Sortino Ratio (1Y)	1.79	-0.21

Profitability

ROE (TTM)

DexCom (DXCM) at 37.67% sits in the top ROE quartile, while Fresenius Medical Care (FMS) at 7.84% is closer to the peer norm — stronger capital efficiency for DXCM.

DXCM

Health Care Equipment & Services industry group

37.67%

Max: 47.61%
DXCM: 37.67%
Q3: 14.36%
Median: 5.45%
Q1: -10.67%
Min: -47.01%

FMS

Health Care Equipment & Services industry group

7.84%

Max: 47.61%
Q3: 14.36%
FMS: 7.84%
Median: 5.45%
Q1: -10.67%
Min: -47.01%

DexCom (DXCM) vs. Fresenius Medical Care (FMS): A comparison of their ROE against the Health Care Equipment & Services industry group benchmark.

Net Margin (TTM)

DexCom (DXCM) at 19.42% retains a top-quartile share of revenue as profit, ahead of Fresenius Medical Care (FMS) at 4.22%, which keeps about the industry-typical share.

DXCM

Health Care Equipment & Services industry group

19.42%

Max: 29.35%
DXCM: 19.42%
Q3: 9.33%
Median: 2.18%
Q1: -6.29%
Min: -28.46%

FMS

Health Care Equipment & Services industry group

4.22%

Max: 29.35%
Q3: 9.33%
FMS: 4.22%
Median: 2.18%
Q1: -6.29%
Min: -28.46%

DexCom (DXCM) vs. Fresenius Medical Care (FMS): A comparison of their net margin against the Health Care Equipment & Services industry group benchmark.

Operating Margin (TTM)

DexCom (DXCM) at 24.34% operates in the top operating margin quartile, ahead of Fresenius Medical Care (FMS) at 9.63%, which runs around its industry’s norm.

DXCM

Health Care Equipment & Services industry group

24.34%

Max: 35.43%
DXCM: 24.34%
Q3: 14.14%
Median: 6.81%
Q1: -0.28%
Min: -16.29%

FMS

Health Care Equipment & Services industry group

9.63%

Max: 35.43%
Q3: 14.14%
FMS: 9.63%
Median: 6.81%
Q1: -0.28%
Min: -16.29%

DexCom (DXCM) vs. Fresenius Medical Care (FMS): A comparison of their operating margin against the Health Care Equipment & Services industry group benchmark.

Profitability Metrics

Profitability metrics for DexCom (DXCM) and Fresenius Medical Care (FMS)
Metric	DXCM	FMS
ROE (TTM)	37.67%	7.84%
ROA (TTM)	11.14%	3.94%
Net Margin (TTM)	19.42%	4.22%
Operating Margin (TTM)	24.34%	9.63%
Gross Margin (TTM)	63.42%	26.46%

Growth

Revenue Growth

DexCom (DXCM) at 15.60% is around its peer norm for revenue growth, while Fresenius Medical Care (FMS) at 1.51% drops into the bottom quartile, signaling weaker demand or pricing momentum.

DexCom (DXCM) vs. Fresenius Medical Care (FMS): A comparison of their Revenue Growth across different time periods.

EPS Growth

Both DexCom (DXCM) at 47.18% and Fresenius Medical Care (FMS) at 83.61% sit in the top peer quartile for EPS growth, so each is compounding per-share earnings faster than typical industry peers.

DexCom (DXCM) vs. Fresenius Medical Care (FMS): A comparison of their EPS Growth across different time periods.

Growth Metrics

Growth metrics for DexCom (DXCM) and Fresenius Medical Care (FMS)
Metric	DXCM	FMS
Revenue Growth (YoY)	15.60%	1.51%
Revenue Growth (3Y CAGR)	17.01%	0.39%
EPS Growth (YoY)	47.18%	83.61%
EPS Growth (3Y CAGR)	36.60%	13.47%

Financial Strength

Current Ratio (MRQ)

DexCom (DXCM) at 1.74 keeps current ratio within its industry’s typical mid-range, while Fresenius Medical Care (FMS) at 0.99 runs in the tighter-liquidity quartile — a thinner cushion against current liabilities for FMS.

DXCM

Health Care Equipment & Services industry group

1.74

Max: 7.59
Q3: 4.00
Median: 1.98
DXCM: 1.74
Q1: 1.37
Min: 0.30

FMS

Health Care Equipment & Services industry group

0.99

Max: 7.59
Q3: 4.00
Median: 1.98
Q1: 1.37
FMS: 0.99
Min: 0.30

DexCom (DXCM) vs. Fresenius Medical Care (FMS): A comparison of their current ratio against the Health Care Equipment & Services industry group benchmark.

Debt / Equity (MRQ)

Both DexCom (DXCM) at 0.55 and Fresenius Medical Care (FMS) at 0.79 fund their balance sheets with roughly industry-typical debt-to-equity mixes.

DXCM

Health Care Equipment & Services industry group

0.55

Max: 1.88
Q3: 0.91
Median: 0.58
DXCM: 0.55
Q1: 0.16
Min: 0.00

FMS

Health Care Equipment & Services industry group

0.79

Max: 1.88
Q3: 0.91
FMS: 0.79
Median: 0.58
Q1: 0.16
Min: 0.00

DexCom (DXCM) vs. Fresenius Medical Care (FMS): A comparison of their debt-to-equity ratio against the Health Care Equipment & Services industry group benchmark.

Financial Strength Metrics

Financial strength metrics for DexCom (DXCM) and Fresenius Medical Care (FMS)
Metric	DXCM	FMS
Current Ratio (MRQ)	1.74	0.99
Debt / Equity (MRQ)	0.55	0.79
Net Debt / EBITDA	-0.28	3.63

Dividends

Dividend Yield (TTM)

DexCom (DXCM) pays no dividend (yield 0.00%) — it may be reinvesting, using buybacks, or simply not returning cash through dividends. Meanwhile Fresenius Medical Care (FMS) reports a yield of 6.30%, ranking against industry peers normally.

DXCM

Health Care Equipment & Services industry group

0.00%

DXCM: 0.00%
Max: 0.00%
Q3: 0.00%
Median: 0.00%
Q1: 0.00%
Min: 0.00%

FMS

Health Care Equipment & Services industry group

6.30%

FMS: 6.30%
Max: 0.00%
Q3: 0.00%
Median: 0.00%
Q1: 0.00%
Min: 0.00%

DexCom (DXCM) vs. Fresenius Medical Care (FMS): A comparison of their dividend yield against the Health Care Equipment & Services industry group benchmark.

Dividend Payout Ratio (TTM)

DexCom (DXCM) pays no dividend (payout 0.00%) — it may be reinvesting, using buybacks, or simply not returning cash through dividends. Meanwhile Fresenius Medical Care (FMS) reports a payout of 50.14%, ranking against industry peers normally.

DXCM

Health Care Equipment & Services industry group

0.00%

DXCM: 0.00%
Max: 0.00%
Q3: 0.00%
Median: 0.00%
Q1: 0.00%
Min: 0.00%

FMS

Health Care Equipment & Services industry group

50.14%

FMS: 50.14%
Max: 0.00%
Q3: 0.00%
Median: 0.00%
Q1: 0.00%
Min: 0.00%

DexCom (DXCM) vs. Fresenius Medical Care (FMS): A comparison of their payout ratio against the Health Care Equipment & Services industry group benchmark.

Dividend Metrics

Dividend metrics for DexCom (DXCM) and Fresenius Medical Care (FMS)
Metric	DXCM	FMS
Dividend Yield (TTM)	0.00%	6.30%
Dividend Payout Ratio (TTM)	0.00%	50.14%

Valuation

P/E Ratio (TTM)

Fresenius Medical Care (FMS) at 13.53 sits in the cheaper P/E ratio quartile, while DexCom (DXCM) at 31.26 is closer to its industry’s usual earnings multiple — a discount for FMS, though growth and earnings durability still matter.

DXCM

Health Care Equipment & Services industry group

31.26

Max: 80.41
Q3: 47.62
DXCM: 31.26
Median: 29.93
Q1: 21.19
Min: 4.21

FMS

Health Care Equipment & Services industry group

13.53

Max: 80.41
Q3: 47.62
Median: 29.93
Q1: 21.19
FMS: 13.53
Min: 4.21

DexCom (DXCM) vs. Fresenius Medical Care (FMS): A comparison of their P/E ratio against the Health Care Equipment & Services industry group benchmark.

P/S Ratio (TTM)

Fresenius Medical Care (FMS) at 0.62 looks cheap on sales in the lower P/S ratio quartile, while DexCom (DXCM) at 5.80 looks rich in the upper quartile — a clear gap in price per dollar of revenue.

DXCM

Health Care Equipment & Services industry group

5.80

Max: 8.80
DXCM: 5.80
Q3: 4.32
Median: 2.13
Q1: 1.10
Min: 0.03

FMS

Health Care Equipment & Services industry group

0.62

Max: 8.80
Q3: 4.32
Median: 2.13
Q1: 1.10
FMS: 0.62
Min: 0.03

DexCom (DXCM) vs. Fresenius Medical Care (FMS): A comparison of their P/S ratio against the Health Care Equipment & Services industry group benchmark.

P/B Ratio (MRQ)

Fresenius Medical Care (FMS) at 0.85 looks cheap against book in the lower P/B ratio quartile, while DexCom (DXCM) at 11.68 carries a premium in the upper quartile — a clear price-to-book gap.

DXCM

Health Care Equipment & Services industry group

11.68

DXCM: 11.68
Max: 11.68
Q3: 6.12
Median: 3.00
Q1: 1.73
Min: -1.31

FMS

Health Care Equipment & Services industry group

0.85

Max: 11.68
Q3: 6.12
Median: 3.00
Q1: 1.73
FMS: 0.85
Min: -1.31

DexCom (DXCM) vs. Fresenius Medical Care (FMS): A comparison of their P/B ratio against the Health Care Equipment & Services industry group benchmark.

Valuation Metrics

Valuation metrics for DexCom (DXCM) and Fresenius Medical Care (FMS)
Metric	DXCM	FMS
P/E Ratio (TTM)	31.26	13.53
P/S Ratio (TTM)	5.80	0.62
P/B Ratio (MRQ)	11.68	0.85
Free Cash Flow Yield (TTM)	2.74%	12.29%